What is Sotyktu?
Sotyktu Side Effects Adults with intermediate to severe plaque psoriasis who can benefit from systemic treatment or phototherapy can be treated with the prescription drug Sotyktu (deucravacitinib), which is a once-daily tablet.
Sotyktu is a novel family of medications known as tyrosine kinase 2 (TYK2) inhibitors that inhibit the activity of the TYK2 protein.
Sotyktu side effects, The immune system component TYK2 plays a part in inflammation and can lead to plaque psoriasis. By lessening the intensity and number of psoriasis lesions, blocking TYK2 helps psoriasis symptoms.
What is Sotyktu used to treat?
Sotyktu side effects, To treat people with mild to severe plaque psoriasis, Sotyktu tablets are used in conjunction with systemic therapy, ultraviolet or UV light therapy, or both. (phototherapy).
On September 9, 2022, the FDA authorised Sotyktu pills as a medication.
Sotyktu Enrollment Form
Click here for more details on Sotyktu's costs, discounts, and patient registration form (also called the Sotyktu start form): Patient Assistance Program for Sotyktu
Information of importance
Sotyktu side effects, Serious negative impacts of sotyktu include:
severe allergy responses. If you experience any of the following signs of a severe allergic response, stop your medication and seek immediate medical attention right away:
- feel a slight swelling of your cheeks, eyes, lips, tongue, or neck; experience difficulty breathing; or tightness in your larynx
- sternum constriction
- itching and rashes
Infections.
Sotyktu side effects, A medication called Sotyktu impacts your defence system. Sotyktu can reduce your immune system's capacity to battle infections and raise your chance of contracting them. While taking Sotyktu, some individuals have developed severe illnesses, including COVID-19 and infections of the lungs, including pneumonia and tuberculosis (TB).